Literature DB >> 15725416

Function of neuropeptide Y and agouti-related protein at weaning: relation to corticosterone, dietary carbohydrate and body weight.

Sarah F Leibowitz1, Kate Sepiashvili, Akira Akabayashi, Olga Karatayev, Zoya Davydova, Jesline T Alexander, Jian Wang, Guo-Qing Chang.   

Abstract

Neuropeptide Y (NPY) and agouti-related protein (AgRP), potent stimulants of feeding, have been linked in adult rats to both corticosterone (CORT) and dietary carbohydrate. To understand the significance of this relationship early in life, measurements were taken of these parameters at different ages around weaning, in rats given a choice of macronutrient diets or maintained on a carbohydrate-rich diet. The results demonstrate that, in both male and female rat pups, the expression and production of NPY and AgRP in the arcuate nucleus (ARC) peak on postnatal day 21 (P21), compared to P15 before weaning and P27 after weaning. These elevated levels of peptide were associated with peak levels of CORT and glucose and also a strong, natural preference for carbohydrate at weaning, which accounted for 55-65% of the pups' total diet. In subgroups defined by their body weight at these stages, rats with as little as 4% lower body weight (compared to higher weight pups) had 30-60% greater expression of NPY and AgRP in the ARC and elevated levels of CORT, with no difference in leptin or insulin. This response was significantly more pronounced at P21 than at P15 or P27. The importance of carbohydrate during this stage was suggested by additional results showing elevated NPY expression, CORT levels, body weight and inguinal fat pad weights in P27 pups raised on a 65% carbohydrate diet vs. 45% carbohydrate. These results suggest that hypothalamic NPY and AgRP, together with CORT, have glucoregulatory as well as feeding stimulatory functions that help mediate the transition from suckling of a fat-rich diet to independent feeding of a carbohydrate-rich diet. During this critical period, the carbohydrate together with the peptides and CORT provide the important signals, including elevated glucose, that promote de novo lipogenesis and enable weanling animals to survive periods of food deprivation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15725416     DOI: 10.1016/j.brainres.2004.12.038

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Early leptin intervention reverses perturbed energy balance regulating hypothalamic neuropeptides in the pre- and postnatal calorie-restricted female rat offspring.

Authors:  Leena Caroline Gibson; Bo-Chul Shin; Yun Dai; William Freije; Sudatip Kositamongkol; John Cho; Sherin U Devaskar
Journal:  J Neurosci Res       Date:  2015-01-29       Impact factor: 4.164

2.  Fasting and 17β-estradiol differentially modulate the M-current in neuropeptide Y neurons.

Authors:  Troy A Roepke; Jian Qiu; Arik W Smith; Oline K Rønnekleiv; Martin J Kelly
Journal:  J Neurosci       Date:  2011-08-17       Impact factor: 6.167

3.  Hypothalamic Non-AgRP, Non-POMC GABAergic Neurons Are Required for Postweaning Feeding and NPY Hyperphagia.

Authors:  Eun Ran Kim; Zhaofei Wu; Hao Sun; Yuanzhong Xu; Leandra R Mangieri; Yong Xu; Qingchun Tong
Journal:  J Neurosci       Date:  2015-07-22       Impact factor: 6.167

4.  Developmental changes in embryonic hypothalamic neurons during prenatal fat exposure.

Authors:  Kinning Poon; Jessica R Barson; Shawn E Fagan; Sarah F Leibowitz
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-06-12       Impact factor: 4.310

5.  Chronic consumption of a low-fat diet leads to increased hypothalamic agouti-related protein and reduced leptin.

Authors:  Jaroslaw Staszkiewicz; Ronald Horswell; George Argyropoulos
Journal:  Nutrition       Date:  2007-07-23       Impact factor: 4.008

6.  Early life exposure to a high fat diet promotes long-term changes in dietary preferences and central reward signaling.

Authors:  S L Teegarden; A N Scott; T L Bale
Journal:  Neuroscience       Date:  2009-05-22       Impact factor: 3.590

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.